Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Clin Exp Obstet Gynecol ; 34(3): 171-4, 2007.
Article in English | MEDLINE | ID: mdl-17937094

ABSTRACT

PURPOSE: To determine if measurement of fetal abdominal subcutaneous tissue thickness (FASTT) at term can predict birth weight, mode of delivery and perinatal outcome. METHODS: A prospective study with 352 normal, singleton pregnancies in the vertex presentation examined with real-time ultrasound at 37-39 weeks' gestation. RESULTS: FASTT was positively correlated with birth weight (Pearson's, r = 0.784, p < 0.001). Fetuses with low FASTT were more likely to be delivered through normal vaginal delivery (7.8 +/- 0.1 mm), while higher FASTT was correlated with operative vaginal delivery (7.9 +/- 0.2 mm) and cesarean section (8.6 +/- 0.3 mm) (ANOVA, p = 0.034). In contrast, FASTT was not correlated with intrapartum CTG, labor duration and Apgar scores. CONCLUSIONS: In normal pregnancies, FASTT at term is positively associated with birth weight. With increasing FASTT the likelihood of operative vaginal and cesarean delivery increases. FASTT is not associated with perinatal outcome.


Subject(s)
Abdominal Fat/anatomy & histology , Birth Weight , Cesarean Section , Fetus/anatomy & histology , Ultrasonography, Prenatal , Abdominal Fat/diagnostic imaging , Biomarkers , Female , Humans , Infant, Newborn , Predictive Value of Tests , Pregnancy , Pregnancy Trimester, Third , Prospective Studies
2.
Eur J Obstet Gynecol Reprod Biol ; 123(2): 188-92, 2005 Dec 01.
Article in English | MEDLINE | ID: mdl-15941615

ABSTRACT

OBJECTIVES: To evaluate the clinical relevance of nuchal cord in normal, vertex, singleton pregnancies at term, and its effect on mode of delivery and perinatal outcome. STUDY DESIGN: Prospective study with 352 normal, singleton pregnancies, with fetuses in the vertex presentation, examined with real-time ultrasound at 37-39 weeks. Health care workers at labour and delivery blinded to previous detection of nuchal cord. RESULTS: Fetuses of nulliparous women with a nuchal cord were more likely to be delivered with operative vaginal or caesarean delivery (n = 153, p < 0.0001). This was not the case with higher parity (n = 199, p = 0.07). There was no difference between nuchal cord (n = 144) and control groups (n = 208) in amniotic fluid quantity at 37-39 weeks (p = 0.554) or intrapartum CTG (p = 0.9). On the other hand, nuchal cord group had lower Apgar scores at 1 and 5 min (p = 0.001 and 0.027 respectively); this difference remained significant when adjusted for birth weight (p = 0.001 and 0.016), but disappeared when adjusted for mode of delivery (p = 0.048 and 0.319). CONCLUSIONS: Nuchal cord in normal pregnancies at term is associated with increased rate of operative vaginal and caesarean delivery in nulliparae. The presence of a nuchal cord results in slightly lower Apgar scores at 1 and 5 min, mainly as a consequence of higher operative delivery rates.


Subject(s)
Delivery, Obstetric/methods , Pregnancy Complications/diagnostic imaging , Umbilical Cord/diagnostic imaging , Female , Humans , Labor Presentation , Obstetric Labor Complications/diagnostic imaging , Pregnancy , Pregnancy Outcome , Prospective Studies , Term Birth , Ultrasonography, Prenatal
3.
Gynecol Obstet Invest ; 59(3): 162-4, 2005.
Article in English | MEDLINE | ID: mdl-15687730

ABSTRACT

Mucocele of the vermiform appendix is caused by mucus retention in its lumen, due to obstruction or hyperproduction. Appendiceal malignancy can be the underlying cause, making accurate preoperative diagnosis imperative. In women, it can sometimes present as an adnexal mass. A rare case of an appendiceal mucocele is presented, mimicking a cystic tumor of the right adnexum, both clinically and ultrasonographically. In addition, serum levels of CA-125 were increased. This is the first case of a mucocele of the appendix simulating an adnexal mass on ultrasound with increased levels of CA-125 to be reported. This clinical entity should be considered in patients presenting on ultrasound with a right-sided adnexal mass as a rare potential diagnosis.


Subject(s)
Appendix , Cecal Diseases/diagnostic imaging , Mucocele/diagnostic imaging , Adnexal Diseases , Aged , CA-125 Antigen/blood , Cecal Diseases/diagnosis , Diagnosis, Differential , Female , Humans , Mucocele/diagnosis , Ultrasonography
4.
Eur J Gynaecol Oncol ; 25(6): 752-4, 2004.
Article in English | MEDLINE | ID: mdl-15597860

ABSTRACT

OBJECTIVE: To determine the frequency of synchronous primary neoplasia of the ovaries in patients with primary malignant neoplasia of the uterus, and to analyze the clinical and histological characteristics of these cases. MATERIALS AND METHODS: Clinicopathological data from a series of patients treated for primary malignant neoplasia of the uterus between 1985 and November 2003 have been studied retrospectively. RESULTS: Synchronous primary neoplasia of the ovaries was found in 13 out of 173 patients (7.5%) treated for primary malignant neoplasia of the uterus. In four patients (2.3%) the histological findings suggested ovarian metastases from primary endometrial adenocarcinoma. In four other cases (2.3%) there was extension of the primary uterine sarcoma to the ovaries. In the remaining five cases (2.9%) primary endometrial adenocarcinoma coexisted with: a) ovarian cystadenocarcinoma in two cases, b) ovarian fibromathecoma in two cases, and c) ovarian tumor of borderline malignancy in one case. CONCLUSIONS: Coexistence of distinct primary neoplasias in the uterus and ovaries is rare. Diagnosis of two primary malignancies in the uterus and ovaries should be based on histological examination. Treatment should be appropriate for both tumors, taking into consideration that treatment of one tumor will not lead to subtreatment of the other.


Subject(s)
Neoplasms, Multiple Primary/diagnosis , Ovarian Neoplasms/diagnosis , Uterine Neoplasms/diagnosis , Adenocarcinoma/diagnosis , Adenocarcinoma/epidemiology , Adenocarcinoma/pathology , Aged , Cystadenocarcinoma/diagnosis , Cystadenocarcinoma/epidemiology , Cystadenocarcinoma/pathology , Female , Greece/epidemiology , Humans , Middle Aged , Neoplasms, Multiple Primary/epidemiology , Neoplasms, Multiple Primary/pathology , Ovarian Neoplasms/epidemiology , Ovarian Neoplasms/pathology , Retrospective Studies , Thecoma/diagnosis , Thecoma/epidemiology , Thecoma/pathology , Uterine Neoplasms/epidemiology , Uterine Neoplasms/pathology
5.
Eur J Gynaecol Oncol ; 25(4): 530-3, 2004.
Article in English | MEDLINE | ID: mdl-15285325

ABSTRACT

INTRODUCTION: Tamoxifen therapy is associated with an increased risk of endometrial carcinoma, and possibly uterine sarcomas. Little is known about hormone receptor expression in mesenchymal tumors of the uterus after tamoxifen therapy. CASES: The cases of two patients with uterine mesenchymal tumors after prolonged tamoxifen therapy due to breast cancer are presented. The expression of estrogen receptors alpha (ERalpha) and beta (ERbeta) and progesterone receptors (PR) was studied immunohistochemically in both cases. Both tumors were negative for ERalpha and positive for ERbeta. In the first case the tumor was negative for PR, while in the second only 20% of nuclei were PR-positive. CONCLUSIONS: Consistent with previous studies, uterine mesenchymal tumors after tamoxifen therapy do not express ERalpha. The results of the present report provide for the first time evidence that tamoxifen might exert a stimulatory effect on the uterus, at least during tumor progression, through ERbeta but not through ERalpha.


Subject(s)
Carcinosarcoma/chemically induced , Endometrial Neoplasms/chemically induced , Receptors, Estrogen/analysis , Tamoxifen/adverse effects , Biomarkers, Tumor/analysis , Biopsy, Needle , Breast Neoplasms/drug therapy , Breast Neoplasms/pathology , Breast Neoplasms/surgery , Carcinosarcoma/pathology , Chemotherapy, Adjuvant , Endometrial Neoplasms/pathology , Estrogen Receptor alpha , Estrogen Receptor beta , Female , Follow-Up Studies , Humans , Immunohistochemistry , Mastectomy/methods , Middle Aged , Neoplasm Staging , Receptors, Estrogen/drug effects , Risk Assessment , Tamoxifen/therapeutic use
6.
Clin Exp Obstet Gynecol ; 31(2): 151-3, 2004.
Article in English | MEDLINE | ID: mdl-15266776

ABSTRACT

Many authors consider sirenomelia to be an extreme form of caudal regression syndrome (CRS), while others argue that they are two distinct entities. Maternal diabetes mellitus is considered to be an important predisposing factor for both CRS and sirenomelia. Two rare cases of diabetic, dizygotic twin pregnancies, each with one normal and one affected fetus are presented. In case 1 the affected fetus had CRS. In case 2 the affected fetus had sirenomelia. The present cases suggest that the pathogenesis of CRS and sirenomelia is more complex than previously thought, that maternal diabetes is not the only underlying pathogenetic mechanism and that genetic or epigenetic factors probably contribute to the formation of these conditions.


Subject(s)
Ectromelia/diagnosis , Lower Extremity Deformities, Congenital/diagnosis , Pregnancy in Diabetics , Twins , Ultrasonography, Prenatal , Adult , Diabetes Mellitus , Diagnosis, Differential , Ectromelia/diagnostic imaging , Ectromelia/pathology , Female , Humans , Infant, Newborn , Lower Extremity Deformities, Congenital/diagnostic imaging , Male , Pregnancy
7.
Eur J Gynaecol Oncol ; 25(3): 384-6, 2004.
Article in English | MEDLINE | ID: mdl-15171326

ABSTRACT

Primitive neuroectodermal tumors (PNETs) of the uterus are very rare. The histogenesis of these tumors is still unknown and the differential diagnosis includes a wide variety of tumor entities. We describe a rare case of a 68-year-old female who presented with persistent vaginal bleeding. Physical examination and CT-scan revealed a large tumor in the uterus. Macroscopically the tumor involved the uterine isthmus. Histological and immunohistochemical examination showed that the tumor fulfilled the diagnostic criteria set for PNET. Only a very small number of cases of PNETs of the uterus have been reported in the literature, thus no definitive conclusions concerning the therapeutic management and prognosis have been ascertained.


Subject(s)
Neuroectodermal Tumors, Primitive/diagnosis , Uterine Neoplasms/diagnosis , Aged , Diagnosis, Differential , Female , Humans , Immunohistochemistry , Neuroectodermal Tumors, Primitive/complications , Neuroectodermal Tumors, Primitive/diagnostic imaging , Neuroectodermal Tumors, Primitive/pathology , Neuroectodermal Tumors, Primitive/surgery , Radiography , Uterine Hemorrhage/etiology , Uterine Neoplasms/complications , Uterine Neoplasms/diagnostic imaging , Uterine Neoplasms/pathology , Uterine Neoplasms/surgery
8.
Eur J Gynaecol Oncol ; 25(1): 116-8, 2004.
Article in English | MEDLINE | ID: mdl-15053079

ABSTRACT

An extremely rare case of a postmenopausal patient with an ovarian Sertoli-Leydig cell tumour and a coexistent vaginal angiomyxoma is reported. A 71-year-old patient was admitted complaining of abdominal distension. A thorough diagnostic evaluation revealed a large tumour of the right ovary, and an oval-shaped greyish-white polypoid vaginal lesion. Total hysterectomy with bilateral salpingooophorectomy and lymph node sampling was performed, followed by excision of the vaginal lesion. Histological examination showed a Sertoli-Leydig cell tumour of the right ovary, and a vaginal angiomyxoma. Twenty-six months after the operation the patient is well with no signs of recurrence. To the best of our knowledge, no case of coexistence of an ovarian Sertoli-Leydig cell tumour with a myxoma has been previously reported.


Subject(s)
Myxoma/diagnosis , Neoplasms, Multiple Primary/diagnosis , Ovarian Neoplasms/diagnosis , Sertoli-Leydig Cell Tumor/diagnosis , Vaginal Neoplasms/diagnosis , Aged , Diagnosis, Differential , Female , Humans , Myxoma/pathology , Myxoma/surgery , Neoplasms, Multiple Primary/pathology , Neoplasms, Multiple Primary/surgery , Ovarian Neoplasms/pathology , Ovarian Neoplasms/surgery , Sertoli-Leydig Cell Tumor/pathology , Sertoli-Leydig Cell Tumor/surgery , Vaginal Neoplasms/pathology , Vaginal Neoplasms/surgery
9.
Gynecol Obstet Invest ; 57(2): 90-2, 2004.
Article in English | MEDLINE | ID: mdl-14671417

ABSTRACT

Endometriosis outside the pelvis is rare and most cases occur in surgical scars after operations involving the female genital tract. Fistulae involving the uterus are also very rare, usually being the result of postpartum and postoperative complications. In the present report, a case of a 44-year-old patient with an endometriotic uterocutaneous fistula is described. The patient presented 6 years after her fourth cesarean section with a painful nodule on the cesarean scar, which was bleeding during menstruation. The lesion extended to the uterine fundus, connecting the endometrial cavity with the skin. This is merely the second case of a uterocutaneous fistula to be reported in the literature and the first case developed on grounds of endometriosis.


Subject(s)
Cesarean Section/adverse effects , Cutaneous Fistula/etiology , Endometriosis/etiology , Uterine Diseases/etiology , Adult , Cutaneous Fistula/physiopathology , Cutaneous Fistula/surgery , Endometriosis/physiopathology , Endometriosis/surgery , Female , Humans , Hysterectomy , Uterine Diseases/physiopathology , Uterine Diseases/surgery
10.
Eur J Gynaecol Oncol ; 24(1): 76-8, 2003.
Article in English | MEDLINE | ID: mdl-12691324

ABSTRACT

Chondrosarcoma of the uterus is an extremely rare type of pure heterologous uterine sarcoma. In the present report a case of myxoid chondrosarcoma that occurred in the uterine corpus of a 46-year-old woman is described together with a brief review of the cases of uterine chondrosarcoma previously reported in the literature.


Subject(s)
Chondrosarcoma/pathology , Uterine Neoplasms/pathology , Biopsy, Needle , Chondrosarcoma/surgery , Female , Follow-Up Studies , Humans , Hysterectomy/methods , Immunohistochemistry , Middle Aged , Risk Assessment , Treatment Outcome , Uterine Neoplasms/surgery
11.
Leuk Lymphoma ; 44(12): 2155-7, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14959864

ABSTRACT

The occurrence of second malignancies is an important late event following the treatment of Hodgkin's disease (HD). Occurrence of a non-Hodgkin's lymphoma (NHL) involving the uterine cervix after treatment for HD has not been previously reported. We describe a rare case of a 34-year old woman, with NHL involving the uterine cervix 7.5 years after treatment for HD. The follow-up of patients treated for HD should also include regular gynecological evaluation. In cases of abnormal findings, accurate diagnosis can only be made histologically.


Subject(s)
Hodgkin Disease/drug therapy , Hodgkin Disease/radiotherapy , Lymphoma, Non-Hodgkin/pathology , Neoplasms, Second Primary/diagnosis , Uterine Cervical Neoplasms/diagnosis , Uterine Cervical Neoplasms/secondary , Adult , Cervix Uteri/pathology , Female , Humans , Immunohistochemistry , Lymphatic Metastasis , Lymphoma/pathology , Time Factors
12.
Eur J Gynaecol Oncol ; 17(1): 49-52, 1996.
Article in English | MEDLINE | ID: mdl-8750515

ABSTRACT

Cases of squamous cell carcinoma arising from mature cystic teratomas of the left ovary are presented. Two of the carcinomas occurred in postmenopausal women 54 and 71 years old and the third in a menstruating woman 42 years old. The two women with well-differentiated squamous cell carcinomas, who had extra ovarian extension of the tumor, died four and eight months postoperatively. The third woman with a poorly-differentiated squamous cell carcinoma, which was confined to the ovary, was alive two years after the operation. The special importance in the prognosis and spreading of tumors is emphasized.


Subject(s)
Carcinoma, Squamous Cell/pathology , Neoplasms, Second Primary/pathology , Ovarian Neoplasms/pathology , Teratoma/pathology , Adult , Aged , Carcinoma, Squamous Cell/secondary , Female , Humans , Intestinal Neoplasms/secondary , Middle Aged , Peritoneal Neoplasms/secondary , Prognosis , Teratoma/secondary
SELECTION OF CITATIONS
SEARCH DETAIL
...